Cargando…
SCY-078 Is Fungicidal against Candida Species in Time-Kill Studies
SCY-078 is an orally bioavailable ß-1,3-glucan synthesis inhibitor (GSI) and the first-in-class of structurally novel triterpene antifungals in clinical development for treating candidemia and invasive candidiasis. In vitro susceptibilities by broth microdilution, antifungal carryover, and time-kill...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328566/ https://www.ncbi.nlm.nih.gov/pubmed/28069658 http://dx.doi.org/10.1128/AAC.01961-16 |
_version_ | 1782510910755045376 |
---|---|
author | Scorneaux, Bernard Angulo, David Borroto-Esoda, Katyna Ghannoum, Mahmoud Peel, Michael Wring, Stephen |
author_facet | Scorneaux, Bernard Angulo, David Borroto-Esoda, Katyna Ghannoum, Mahmoud Peel, Michael Wring, Stephen |
author_sort | Scorneaux, Bernard |
collection | PubMed |
description | SCY-078 is an orally bioavailable ß-1,3-glucan synthesis inhibitor (GSI) and the first-in-class of structurally novel triterpene antifungals in clinical development for treating candidemia and invasive candidiasis. In vitro susceptibilities by broth microdilution, antifungal carryover, and time-kill dynamics were determined for three reference (ATCC) strains (Candida albicans 90028, Candida parapsilosis 90018, and Candida tropicalis 750), a quality-control (QC) strain (Candida krusei 6258), and four other strains (C. albicans MYA-2732, 64124, and 76485 and Candida glabrata 90030). Caspofungin (CASP), fluconazole (FLC), and voriconazole (VRC) were comparators. For time-kill experiments, SCY-078 and CASP were evaluated at 0.25, 1, 2, 4, 8, and 16 times the MIC(80), and FLU and VRC were evaluated at 4× MIC(80). The time to reach 50%, 90%, and 99.9% reduction in the number of CFUs from the starting inoculum was determined. Net change in the number of CFU per milliliter was used to determine 50% and 90% effective concentrations and maximum effect (EC(50), EC(90), and E(max), respectively). The SCY-078 MIC range was between 0.0625 and 1 μg/ml and generally similar to that of CASP. Antifungal carryover was not observed for SCY-078. SCY-078 was fungicidal against seven isolates at ≥4× MIC (kill of ≥3 log(10)) and achieved a 1.7-log(10) reduction in CFU count/milliliter against C. albicans 90028. CASP behaved similarly against each isolate and achieved a 1.5-log(10) reduction in the number of CFU/milliliter against C. albicans 90028. Reductions of 50% in CFU count/milliliter were achieved rapidly (1 to 2.8 h); fungicidal endpoints were reached at 12.1 to 21.8 h at ≥4× MIC. EC(90) was reached at ∼5× MIC at each time point to 24 h. The EC(50) and EC(90) values were generally similar (8 to 24 h). Time-kill behavior of CASP was similar to that of SCY-078. FLC and VRC were fungistatic. Overall, SCY-078 has primarily fungicidal activity against Candida spp. and behaved comparably to CASP. |
format | Online Article Text |
id | pubmed-5328566 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-53285662017-03-09 SCY-078 Is Fungicidal against Candida Species in Time-Kill Studies Scorneaux, Bernard Angulo, David Borroto-Esoda, Katyna Ghannoum, Mahmoud Peel, Michael Wring, Stephen Antimicrob Agents Chemother Pharmacology SCY-078 is an orally bioavailable ß-1,3-glucan synthesis inhibitor (GSI) and the first-in-class of structurally novel triterpene antifungals in clinical development for treating candidemia and invasive candidiasis. In vitro susceptibilities by broth microdilution, antifungal carryover, and time-kill dynamics were determined for three reference (ATCC) strains (Candida albicans 90028, Candida parapsilosis 90018, and Candida tropicalis 750), a quality-control (QC) strain (Candida krusei 6258), and four other strains (C. albicans MYA-2732, 64124, and 76485 and Candida glabrata 90030). Caspofungin (CASP), fluconazole (FLC), and voriconazole (VRC) were comparators. For time-kill experiments, SCY-078 and CASP were evaluated at 0.25, 1, 2, 4, 8, and 16 times the MIC(80), and FLU and VRC were evaluated at 4× MIC(80). The time to reach 50%, 90%, and 99.9% reduction in the number of CFUs from the starting inoculum was determined. Net change in the number of CFU per milliliter was used to determine 50% and 90% effective concentrations and maximum effect (EC(50), EC(90), and E(max), respectively). The SCY-078 MIC range was between 0.0625 and 1 μg/ml and generally similar to that of CASP. Antifungal carryover was not observed for SCY-078. SCY-078 was fungicidal against seven isolates at ≥4× MIC (kill of ≥3 log(10)) and achieved a 1.7-log(10) reduction in CFU count/milliliter against C. albicans 90028. CASP behaved similarly against each isolate and achieved a 1.5-log(10) reduction in the number of CFU/milliliter against C. albicans 90028. Reductions of 50% in CFU count/milliliter were achieved rapidly (1 to 2.8 h); fungicidal endpoints were reached at 12.1 to 21.8 h at ≥4× MIC. EC(90) was reached at ∼5× MIC at each time point to 24 h. The EC(50) and EC(90) values were generally similar (8 to 24 h). Time-kill behavior of CASP was similar to that of SCY-078. FLC and VRC were fungistatic. Overall, SCY-078 has primarily fungicidal activity against Candida spp. and behaved comparably to CASP. American Society for Microbiology 2017-02-23 /pmc/articles/PMC5328566/ /pubmed/28069658 http://dx.doi.org/10.1128/AAC.01961-16 Text en Copyright © 2017 Scorneaux et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (http://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Pharmacology Scorneaux, Bernard Angulo, David Borroto-Esoda, Katyna Ghannoum, Mahmoud Peel, Michael Wring, Stephen SCY-078 Is Fungicidal against Candida Species in Time-Kill Studies |
title | SCY-078 Is Fungicidal against Candida Species in Time-Kill Studies |
title_full | SCY-078 Is Fungicidal against Candida Species in Time-Kill Studies |
title_fullStr | SCY-078 Is Fungicidal against Candida Species in Time-Kill Studies |
title_full_unstemmed | SCY-078 Is Fungicidal against Candida Species in Time-Kill Studies |
title_short | SCY-078 Is Fungicidal against Candida Species in Time-Kill Studies |
title_sort | scy-078 is fungicidal against candida species in time-kill studies |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328566/ https://www.ncbi.nlm.nih.gov/pubmed/28069658 http://dx.doi.org/10.1128/AAC.01961-16 |
work_keys_str_mv | AT scorneauxbernard scy078isfungicidalagainstcandidaspeciesintimekillstudies AT angulodavid scy078isfungicidalagainstcandidaspeciesintimekillstudies AT borrotoesodakatyna scy078isfungicidalagainstcandidaspeciesintimekillstudies AT ghannoummahmoud scy078isfungicidalagainstcandidaspeciesintimekillstudies AT peelmichael scy078isfungicidalagainstcandidaspeciesintimekillstudies AT wringstephen scy078isfungicidalagainstcandidaspeciesintimekillstudies |